Safety, Tolerability, and PK/PD of CIGB-814 in Chinese Health Participants

Abroad (travel likely)RecruitingPHASE1

Conditions

Rheumatoid Arthritis (RA)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Peking University People's Hospital, Beijing, Beijing Municipality, China
Contact: Study coordinator (Yi Fang, MD) · fygk7000@163.com · 010-66583834

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Imaging of Lymphatic Vessels in People With Rheumatoid Arthritis (RA)

Rheumatoid Arthritis

Abroad (travel likely)RecruitingPHASE1

Rochester, United States

A Study to Evaluate the Safety and Activity of SAR448501/DR-0201 in Patients With Autoimmune Rheumatic Diseases

Systemic Lupus Erythematosus (SLE) · Rheumatoid Arthritis (RA)

Abroad (travel likely)RecruitingPHASE1

Brisbane, Australia · Melbourne, Australia

A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Rheumatoid Arthritis

Rheumatoid Arthritis (RA

Abroad (travel likely)RecruitingPHASE1

Erlangen, Germany · Heidelberg, Germany

Effect of JAK Inhibitor on Erosion Healing in RA

Rheumatoid Arthritis

Abroad (travel likely)RecruitingPHASE4

Hong Kong, Hong Kong